- Home
- EB vs NMRA Comparison
EB vs NMRA Comparison
Compare EB & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EB
- NMRA
- Stock Information
- Founded
- EB 2003
- NMRA 2019
- Country
- EB United States
- NMRA United States
- Employees
- EB N/A
- NMRA N/A
- Industry
- EB EDP Services
- NMRA
- Sector
- EB Technology
- NMRA
- Exchange
- EB Nasdaq
- NMRA Nasdaq
- Market Cap
- EB 226.8M
- NMRA 268.5M
- IPO Year
- EB 2018
- NMRA 2023
- Fundamental
- Price
- EB $2.23
- NMRA $1.73
- Analyst Decision
- EB Buy
- NMRA Hold
- Analyst Count
- EB 2
- NMRA 8
- Target Price
- EB $5.25
- NMRA $5.83
- AVG Volume (30 Days)
- EB 457.7K
- NMRA 498.0K
- Earning Date
- EB 11-06-2025
- NMRA 11-11-2025
- Dividend Yield
- EB N/A
- NMRA N/A
- EPS Growth
- EB N/A
- NMRA N/A
- EPS
- EB N/A
- NMRA N/A
- Revenue
- EB $300,856,000.00
- NMRA N/A
- Revenue This Year
- EB N/A
- NMRA N/A
- Revenue Next Year
- EB $9.53
- NMRA N/A
- P/E Ratio
- EB N/A
- NMRA N/A
- Revenue Growth
- EB N/A
- NMRA N/A
- 52 Week Low
- EB $1.81
- NMRA $0.61
- 52 Week High
- EB $4.12
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- EB 33.81
- NMRA 47.30
- Support Level
- EB $2.33
- NMRA $1.74
- Resistance Level
- EB $2.44
- NMRA $1.90
- Average True Range (ATR)
- EB 0.10
- NMRA 0.12
- MACD
- EB -0.03
- NMRA -0.02
- Stochastic Oscillator
- EB 1.13
- NMRA 10.94
About EB Eventbrite Inc.
Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. The company's two-sided marketplace connects creators and consumers every month to share their passions, artistry, and causes through live experiences. Creators use its self-service ticketing and marketing tools to plan, promote, and sell tickets to their events, and event seekers use its website and mobile application to discover and purchase tickets to experiences. Geographically, it generates maximum revenue from the United States. The company generates revenues principally from service fees and payment processing fees from the sale of paid tickets on its platform.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.